These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32819233)

  • 21. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
    Syder AJ; Lee H; Zeisel MB; Grove J; Soulier E; Macdonald J; Chow S; Chang J; Baumert TF; McKeating JA; McKelvy J; Wong-Staal F
    J Hepatol; 2011 Jan; 54(1):48-55. PubMed ID: 20932595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
    Campos GRF; Bittar C; Jardim ACG; Shimizu JF; Batista MN; Paganini ER; Assis LR; Bartlett C; Harris M; Bolzani VDS; Regasini LO; Rahal P
    J Gen Virol; 2017 Jul; 98(7):1693-1701. PubMed ID: 28699869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
    Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
    Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro.
    Sellitto G; Faruolo A; de Caprariis P; Altamura S; Paonessa G; Ciliberto G
    Bioorg Med Chem; 2010 Aug; 18(16):6143-8. PubMed ID: 20638289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
    Good SS; Moussa A; Zhou XJ; Pietropaolo K; Sommadossi JP
    PLoS One; 2020; 15(1):e0227104. PubMed ID: 31914458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
    Liao Y; El-Fakkarany E; Lönnerdal B; Redwan EM
    J Med Microbiol; 2012 Mar; 61(Pt 3):375-383. PubMed ID: 22052996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methanolic Extract of
    Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.
    Bocchetta S; Maillard P; Yamamoto M; Gondeau C; Douam F; Lebreton S; Lagaye S; Pol S; Helle F; Plengpanich W; Guérin M; Bourgine M; Michel ML; Lavillette D; Roingeard P; le Goff W; Budkowska A
    PLoS One; 2014; 9(3):e92140. PubMed ID: 24646941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C viral entry inhibitors prolong viral suppression by replication inhibitors in persistently-infected Huh7 cultures.
    Bush CO; Greenstein AE; Delaney WE; Beran RK
    PLoS One; 2013; 8(6):e65273. PubMed ID: 23755208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors.
    Ryu HC; Windisch M; Lim JW; Choi I; Lee EK; Yoo HH; Kim TK
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):462-468. PubMed ID: 33455472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anti-HCV entry activity studies of β-cyclodextrin-pentacyclic triterpene conjugates.
    Xiao S; Wang Q; Si L; Shi Y; Wang H; Yu F; Zhang Y; Li Y; Zheng Y; Zhang C; Wang C; Zhang L; Zhou D
    ChemMedChem; 2014 May; 9(5):1060-70. PubMed ID: 24623716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.
    Chamoun-Emanuelli AM; Pecheur EI; Simeon RL; Huang D; Cremer PS; Chen Z
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2571-81. PubMed ID: 23529728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and rational design of hepatitis C virus entry inhibitory peptides derived from GB virus A NS5A.
    Liu X; Huang Y; Cheng M; Pan L; Si Y; Li G; Niu Y; Zhao L; Zhao J; Li X; Chen Y; Yang W
    J Virol; 2013 Feb; 87(3):1649-57. PubMed ID: 23175359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HCV effect of Lentinula edodes mycelia solid culture extracts and low-molecular-weight lignin.
    Matsuhisa K; Yamane S; Okamoto T; Watari A; Kondoh M; Matsuura Y; Yagi K
    Biochem Biophys Res Commun; 2015 Jun; 462(1):52-7. PubMed ID: 25935479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke.
    Elsebai MF; Koutsoudakis G; Saludes V; Pérez-Vilaró G; Turpeinen A; Mattila S; Pirttilä AM; Fontaine-Vive F; Mehiri M; Meyerhans A; Diez J
    J Virol; 2016 Feb; 90(4):1918-30. PubMed ID: 26656684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.